ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,126.40
-0.19%
S&P ASX All Technology
3,366.70
-1.47%
Brent Oil
73.455
-1.48%
US Dollar vs AUD
1.45563
0.51%
Bitcoin
63,641.29
-0.98%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Talis Biomedical Corporation (TLIS)

  7. Talis Biomedical Corporation (TLIS) News

TLIS

Talis Biomedical (TLIS)

Talis Biomedical Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TLIS
DateTimeSourceHeadlineSymbolCompany
10/09/202406:37Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TLISTalis Biomedical Corporation
10/09/202406:37Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TLISTalis Biomedical Corporation
10/09/202406:33Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TLISTalis Biomedical Corporation
10/09/202406:32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TLISTalis Biomedical Corporation
04/09/202407:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
26/08/202422:58IH Market NewsIBM Closes China Research Division, Uber Fined $324M, Starliner to Return Without AstronautsNASDAQ:TLISTalis Biomedical Corporation
24/08/202406:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
20/08/202406:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLISTalis Biomedical Corporation
15/08/202406:27Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:TLISTalis Biomedical Corporation
08/08/202409:48Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
07/08/202406:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
08/05/202422:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLISTalis Biomedical Corporation
27/01/202408:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
15/11/202300:00GlobeNewswire Inc.Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNASDAQ:TLISTalis Biomedical Corporation
02/09/202307:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
11/08/202307:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TLISTalis Biomedical Corporation
11/08/202306:46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLISTalis Biomedical Corporation
11/08/202306:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
11/08/202306:05GlobeNewswire Inc.Talis Biomedical Announces Second Quarter 2023 Financial Results and Business UpdateNASDAQ:TLISTalis Biomedical Corporation
03/08/202322:00GlobeNewswire Inc.Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023NASDAQ:TLISTalis Biomedical Corporation
02/08/202322:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
02/08/202322:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
02/08/202322:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
02/08/202322:00GlobeNewswire Inc.Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)NASDAQ:TLISTalis Biomedical Corporation
27/07/202322:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
27/07/202322:00GlobeNewswire Inc.New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product MenuNASDAQ:TLISTalis Biomedical Corporation
24/07/202322:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
24/07/202322:00GlobeNewswire Inc.Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:TLISTalis Biomedical Corporation
19/07/202307:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
05/07/202322:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
 Showing the most relevant articles for your search:NASDAQ:TLIS

Your Recent History

NASDAQ
IEI
iShares 3 to 7 Year Trea...
BIT
NSCITA1G0ED3
European Financial Stabi...
TG
A3K5QH
Unilever
COIN
SOLIDETH
Solidly
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved